Endo Health Solutions (NSDQ:ENDP) said it’s selling its HealthTronics urology business to Altaris Capital Partners for up to $130 million, including milestones.
Urology
Silk: a cell-free alternative for regenerating bladder tissue
By Scott Howe
Layoffs ahead as Urologix restructures
American Medical Systems wins 510(k) clearance for transvaginal sling
American Medical Systems lands CE Mark for transvaginal sling
Uroplasty lands expanded reimbursement for overactive bladder treatment system
Pelvic mesh plaintiffs accuse Ethicon of destroying evidence
Plaintiffs in the multi-district pelvic mesh litigation against Johnson & Johnson‘s (NYSE:JNJ) Ethicon subsidiary want a federal judge to impose "severe sanctions" for the company’s alleged mishandling and destruction of 10s of thousands of documents in the case.
Uroplasty jumps on reimbursement win from Humana
Laborie Medical buys UroMed’s pelvic rehab biz
Laborie Medical Technologies said it acquired the pelvic muscle rehabilitation business of UroMed Technology for an undisclosed amount.
Toronto-based Laborie, which is owned by private equity company Audax Group, said the UroMed business expands its offering in the pelvic muscle rehab and conservative therapy space.
Robotic surgery: Intuitive Surgical touts independent prostatectomy study
Intuitive Surgical (NSDQ:ISRG), beset by a series of studies questioning the value of its da Vinci surgical robot, is touting a large independent study showing that minimally invasive prostatectomies are safer than traditional, open surgical techniques.
Baxter makes a smaller buy with $9.5M acquisition of FlowSense
Corrected September 11, 2013, at 3:30 p.m.*